Wayland Group Corp. (MRRCF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerWayland Group Corp. (MRRCF) trades at $0.00001. Wayland Group Corp. produces and sells medical and non-medical cannabis in Canada and internationally. The company offers a variety of cannabis strains under multiple brand names. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for MRRCF: MRRCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Wayland Group Corp. (MRRCF) Healthcare & Pipeline Overview
Wayland Group Corp. is a Canadian cannabis company producing and selling medical and non-medical cannabis products internationally. Operating in the specialty and generic drug manufacturing sector, Wayland offers diverse cannabis strains under brands like Kiwi and Northern Harvest, targeting both medical patients and recreational consumers.
What Is the Investment Thesis for MRRCF?
Investing in Wayland Group Corp. (MRRCF) presents a high-risk, high-reward scenario. The company's negative profit margin of -2079.4% and gross margin of -154.9% indicate significant financial challenges. The company's success hinges on achieving substantial revenue growth and improved operational efficiency. Potential catalysts include expansion into new international markets and the introduction of innovative cannabis products. However, investors should be aware of the risks associated with the OTC market and the company's current financial performance. The company's beta of -44.34 suggests an inverse correlation with the market, which may offer some diversification benefits but also reflects the company's unique risk profile.
Based on FMP financials and quantitative analysis
MRRCF Key Highlights
Market Cap of $0.00B indicates a micro-cap company with limited resources and higher volatility.
- P/E Ratio of -0.00 suggests the company is not currently profitable.
- Profit Margin of -2079.4% highlights significant losses and operational inefficiencies.
- Gross Margin of -154.9% indicates the company is selling products below cost.
- Beta of -44.34 suggests an inverse correlation with the market, indicating unique risk profile.
Who Are MRRCF's Competitors?
MRRCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.91 | -3.54% | — | |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.59 | +42.55% | $7.59M | — |
| BFRI Biofrontera Inc. | $0.89 | -12.23% | $11.4M | — |
| COSM COSM | $0.35 | -9.03% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.27 | -4.94% | $20.9M | — |
| AYTU Aytu BioPharma, Inc. | $2.04 | -1.45% | $21.9M | — |
| TXMD TherapeuticsMD, Inc. | $2.01 | -1.95% | $24.0M | — |
| CPHI CPHI | $0.65 | -0.61% | $27.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MRRCF's Key Strengths?
Established brands in the Canadian cannabis market.
- Diverse product portfolio with CBD, balanced, and THC strains.
- International expansion potential.
- Subsidiary of Maricann Group Inc.
What Are MRRCF's Weaknesses?
Negative profit margin and gross margin.
- Limited market capitalization.
- High beta value indicating high volatility.
- OTC market trading with associated risks.
What Are the Key Risks for MRRCF?
Intense competition in the cannabis industry leading to pricing pressures and market share erosion.
- Changing regulatory landscape impacting the company's operations and compliance costs.
- Fluctuations in cannabis prices affecting revenue and profitability.
- Limited access to capital hindering growth and expansion plans.
- Negative profit margin and gross margin indicating financial instability.
What Are MRRCF's Competitive Advantages?
- Brand recognition through established brands like Kiwi and Northern Harvest.
- Proprietary cannabis strains and formulations.
- Established distribution network in Canada.
- International expansion potential.
What Does MRRCF Do?
Wayland Group Corp., established in 2013 and based in Oakville, Canada, is a producer and seller of medical and non-medical cannabis. The company caters to cannabis patients and consumers both in Canada and on the international market. Wayland Group operates as a subsidiary of Maricann Group Inc. Wayland offers a diverse portfolio of cannabis strains, including CBD, balanced, and THC varieties, marketed under various brand names such as Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann. These brands allow the company to target different consumer segments and preferences within the cannabis market. The company's focus is on cultivating and distributing cannabis products to meet the demands of both medical and recreational users. Wayland Group's operations are primarily based in Canada, but the company also aims to expand its reach internationally. The company's strategy involves developing a range of products and brands to capture a significant share of the cannabis market. Wayland Group's business model is centered around the production, distribution, and sale of cannabis products, with a focus on quality and innovation.
What Products and Services Does MRRCF Offer?
- Produces medical cannabis for patients.
- Produces non-medical cannabis for consumers.
- Sells cannabis products in Canada.
- Sells cannabis products internationally.
- Offers CBD cannabis strains.
- Offers balanced cannabis strains.
- Offers THC cannabis strains.
How Does MRRCF Make Money?
- Cultivates and processes cannabis plants.
- Packages and brands cannabis products.
- Distributes cannabis products through various channels.
- Sells cannabis products directly to consumers and retailers.
What Industry Does MRRCF Operate In?
Wayland Group Corp. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing competition as more companies enter the space and as legalization expands. Wayland Group competes with other cannabis producers and distributors, both in Canada and internationally. The company's ability to differentiate its products and establish a strong brand presence will be crucial for success. The industry is also subject to changing consumer preferences and regulatory requirements, which can impact the company's operations and financial performance.
Who Are MRRCF's Key Customers?
- Medical cannabis patients in Canada.
- Recreational cannabis consumers in Canada.
- International cannabis consumers.
- Retailers and distributors of cannabis products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Wayland Group Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Burlington, CA. The company is led by CEO David Miller. MRRCF has traded publicly since 2001.
Key Financial Metrics
Return on assets is -69.3%, showing how much profit it generates from its asset base. A current ratio of 3.90 indicates the company holds enough short-term assets to cover its near-term obligations.
MRRCF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
MRRCF Latest News
-
Claim Deadline Extended to September 30, 2026 in Wayland Group Corp. (formerly Maricann Group Corp.) Securities Class Action Settlement
Yahoo! Finance: MRRCF News · Aug 14, 2026
-
Stocks That Hit 52-Week Lows On Thursday
· Oct 10, 2019
-
Stocks That Hit 52-Week Lows On Friday
· Oct 4, 2019
MRRCF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MRRCF.
Price Targets
Wall Street price target analysis for MRRCF.
MRRCF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MRRCF; grades run from A+ (80-100) to F (below 30).
Latest News
Leadership: David Miller
Managing
David Miller currently manages 68 employees at Wayland Group Corp. Therefore, a comprehensive background profile cannot be constructed at this time. Further research would be required to ascertain his specific expertise and experience within the cannabis industry or related fields.
Track Record: Due to limited information, David Miller's specific achievements, strategic decisions, and company milestones under his leadership at Wayland Group Corp. cannot be accurately assessed. Additional data is needed to evaluate his impact on the company's performance and strategic direction. His tenure length is also unknown.
MRRCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Wayland Group Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to companies on more regulated exchanges.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater price volatility.
- Limited regulatory oversight.
- Verify the company's legal registration and business licenses.
- Review available financial statements and assess their accuracy.
- Research the background and experience of the company's management team.
- Evaluate the company's business model and competitive landscape.
- Assess the company's compliance with relevant regulations.
- Understand the risks associated with the OTC market and the company's specific circumstances.
- Consult with a qualified financial advisor before investing.
- Company has been in operation since 2013.
- Company has a physical headquarters in Oakville, Canada.
- Company has a range of cannabis products under multiple brand names.
- Company is a subsidiary of Maricann Group Inc.
MRRCF Healthcare Stock FAQ
What does Wayland Group Corp. do?
Wayland Group Corp. is a Canadian cannabis company involved in the production and sale of both medical and non-medical cannabis products.
What do analysts say about MRRCF stock?
There is currently no analyst coverage available for MRRCF (Wayland Group Corp.). This lack of coverage may be due to the company's small market capitalization, OTC listing, and financial challenges.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available for in-depth analysis.
- OTC market carries inherent risks.
- Analyst coverage is non-existent.